Pine Valley Investments’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.73M Buy
17,403
+24
+0.1% +$11.5K 0.34% 72
2026
Q1
$8.54M Buy
17,379
+185
+1% +$100K 0.39% 65
2025
Q4
$9.96M Sell
17,194
-118
-0.7% -$66.7K 0.46% 52
2025
Q3
$8.4M Sell
17,312
-431
-2% -$201K 0.41% 63
2025
Q2
$7.2M Buy
17,743
+521
+3% +$218K 0.4% 66
2025
Q1
$8.57M Sell
17,222
-454
-3% -$246K 0.52% 48
2024
Q4
$9.2M Buy
17,676
+769
+5% +$423K 0.55% 41
2024
Q3
$10.5M Buy
16,907
+10
+0.1% +$5.92K 0.63% 32
2024
Q2
$9.34M Sell
16,897
-3
-0% -$1.72K 0.61% 34
2024
Q1
$9.82M Buy
16,900
+145
+0.9% +$81.4K 0.66% 32
2023
Q4
$8.89M Buy
16,755
+892
+6% +$432K 0.64% 32
2023
Q3
$8.03M Buy
15,863
+84
+0.5% +$44.8K 0.73% 27
2023
Q2
$8.23M Buy
15,779
+12,668
+407% +$6.84M 0.81% 24
2023
Q1
$1.66M Buy
+3,111
New +$1.75M 0.25% 91

Other funds holding TMO

Pine Valley Investments's TMO Position: Q2 2026 in Review

Pine Valley Investments increased its Thermo Fisher Scientific (TMO) stake by 0.14% in Q2 2026, buying an estimated $11.5K and bringing the position to 17,403 shares worth $8.73M. The position accounts for 0.34% of the portfolio, ranked #72.

Pine Valley Investments first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $10.5M in Q3 2024. 1,412 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pine Valley Investments held 17,403 shares of Thermo Fisher Scientific worth $8.73M as of Q2 2026.
  • Pine Valley Investments bought 24 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.5K.
  • Thermo Fisher Scientific made up 0.34% of Pine Valley Investments's portfolio in Q2 2026, its #72 holding.
  • Pine Valley Investments first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Pine Valley Investments's Thermo Fisher Scientific position peaked at $10.5M in Q3 2024.
  • 1,412 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.